United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0220_bce0f9d7-f30d-4462-a8d3-54dd18947a8f
- Product NDC
- 71335-0220
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091124
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE in 1 BOTTLE (71335-0220-0) · 71335-0220-0
- 30 CAPSULE in 1 BOTTLE (71335-0220-1) · 71335-0220-1
- 90 CAPSULE in 1 BOTTLE (71335-0220-2) · 71335-0220-2
- 60 CAPSULE in 1 BOTTLE (71335-0220-3) · 71335-0220-3
- 120 CAPSULE in 1 BOTTLE (71335-0220-4) · 71335-0220-4
- 100 CAPSULE in 1 BOTTLE (71335-0220-5) · 71335-0220-5
- 28 CAPSULE in 1 BOTTLE (71335-0220-6) · 71335-0220-6
- 112 CAPSULE in 1 BOTTLE (71335-0220-7) · 71335-0220-7
- 84 CAPSULE in 1 BOTTLE (71335-0220-8) · 71335-0220-8
- 180 CAPSULE in 1 BOTTLE (71335-0220-9) · 71335-0220-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →